TrakCel design, deploy and support digital Cellular Orchestration Solutions that track and manage all the components of the Cell and Gene Therapy supply chain, helping therapy developers to deliver therapies to patients safely and efficiently for both clinical and commercial stage therapies. For each Advance Therapy Patient journey, from sample collection through logistics, manufacturing and final treatment, TrakCel's flagship platform, OCELLOS orchestrates every step, providing a comprehensive chain of custody, chain of identity and traceability throughout. Always remembering there is a patient at the end of everything we do. We innovate. We unite. We transform tomorrow. Want to know more about how TrakCel could transform your therapy supply chain, get in touch and book a free product demo. Join us. See the journey.
Looking for a particular TrakCel employee's phone or email?
The TrakCel annual revenue was $14.7 million in 2026.
Ravi Nalliah is the CEO and Co-Founder of TrakCel.
74 people are employed at TrakCel.
The NAICS codes for TrakCel are [54, 5417, 541713, 541, 54171].
The SIC codes for TrakCel are [87, 873].